BillionToOne, Inc. (BLLN) stock
BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
$97.50+1.19 (+1.24%)
Close on Nov 17, 2026Market cap $4.60BP/E –Yield –
BillionToOne price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
BillionToOne's price to sales ratio was 11.3× on Nov 11, 2026, against 5.7× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 11.3× | +7.7 |
| 2025 | Dec 31, 2025 | 3.6× | – |
See a number that looks wrong?